Does neurologic deterioration help to differentiate between pseudoprogression and true disease progression in newly diagnosed glioblastoma multiforme?

A. D. Singh, J. C. Easaw

Abstract


Enlarging or new lesions frequently appear on magnetic resonance imaging (MRI) after concurrent administration of radiation therapy and temozolomide in glioblastoma multiforme (GBM) patients. However, in nearly half such cases, the observed radiologic changes are not due to true disease progression, but instead are a result of a post-radiation inflammatory state called “pseudoprogression.” Retrospective studies have reported that neurologic deterioration at the time of the post-chemoradiotherapy MRI is found more commonly in patients with true disease progression. We report a GBM patient with both radiologic progression on the post-chemoradiotherapy MRI and concomitant neurologic deterioration, and we caution against incorporating clinical deterioration into the management schema of patients with possible pseudoprogression.


Full Text:

PDF HTML


DOI: http://dx.doi.org/10.3747/co.19.983






Copyright © 2019 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)